Stemline Therapeutics Inc (NASDAQ:STML)

17.75
Delayed Data
As of 4:00pm ET
 +0.15 / +0.85%
Today’s Change
6.35
Today|||52-Week Range
18.00
+13.78%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Stemline Therapeutics Inc have a median target of 38.00, with a high estimate of 41.00 and a low estimate of 22.00. The median estimate represents a +114.08% increase from the last price of 17.75.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Stemline Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.67
Sales
$249.5K
Reporting Date
TBD

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 0.98%
 
 
 
 
 
 
Growthannually -24.81%
 
 
 
 
 
 

Sales

Growthquarterly -16.67%
 
 
 
 
 
 
Growthannually 2.27%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.